Quarterly report · Q3
2934.TEDINET S100QLF7
Period2022-06-01 → 2023-02-28
Filed2023-04-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 35
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥12.7bn | 2022-06-01 → 2023-02-28 | Cons. | Net sales |
| Revenue | ¥11.9bn | 2021-06-01 → 2022-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥7.4bn | 2021-06-01 → 2022-02-28 | Cons. | Net sales |
| Operating income | −¥690m | 2022-06-01 → 2023-02-28 | Cons. | Operating income |
| Operating income | ¥575m | 2021-06-01 → 2022-02-28 | Cons. | Operating income |
| Ordinary income | −¥709m | 2022-06-01 → 2023-02-28 | Cons. | Ordinary income |
| Ordinary income | ¥712m | 2021-06-01 → 2022-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥550m | 2021-06-01 → 2022-02-28 | Cons. | Ordinary income |
| Profit before tax | −¥710m | 2022-06-01 → 2023-02-28 | Cons. | Income before income taxes |
| Profit before tax | ¥550m | 2021-06-01 → 2022-02-28 | Cons. | Income before income taxes |
| Net income (owners) | −¥604m | 2022-06-01 → 2023-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥401m | 2021-06-01 → 2022-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥353m | 2021-06-01 → 2022-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥559m | 2022-06-01 → 2023-02-28 | Cons. | Profit loss |
| Net income | ¥353m | 2021-06-01 → 2022-02-28 | Cons. | Profit loss |
| Total assets | ¥7.8bn | at 2023-02-28 | Cons. | Assets |
| Total assets | ¥6.1bn | at 2022-05-31 | Cons. | Assets |
| Total assets | ¥5.5bn | at 2022-02-28 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥3.8bn | at 2023-02-28 | Cons. | Liabilities |
| Total liabilities | ¥1.9bn | at 2022-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥4.0bn | at 2023-02-28 | Cons. | Net assets |
| Net assets / equity | ¥4.2bn | at 2022-05-31 | Cons. | Net assets |
| Net assets / equity | ¥4.1bn | at 2022-02-28 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.4bn | at 2023-02-28 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.0bn | at 2022-05-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥-131.07 | 2022-06-01 → 2023-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-54.37 | 2022-12-01 → 2023-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥90.64 | 2021-06-01 → 2022-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥80.6 | 2021-06-01 → 2022-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.28 | 2021-12-01 → 2022-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥86.68 | 2021-06-01 → 2022-05-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥76.33 | 2021-06-01 → 2022-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 48.3% | at 2023-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.8% | at 2022-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.5% | at 2022-02-28 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 35
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-06-01 → 2023-02-28 | −¥139m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-06-01 → 2023-02-28 | −¥139m |
| Reconciling Itemsreconciling | segment profit | 2022-06-01 → 2023-02-28 | −¥385m |
| jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥4.0bn |
| jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥3.9bn |
| jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segment | revenue intersegment | 2022-06-01 → 2023-02-28 | ¥139m |
| jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segment | segment profit | 2022-06-01 → 2023-02-28 | ¥19m |
| jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥3.0bn |
| jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥3.0bn |
| jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segment | segment profit | 2022-06-01 → 2023-02-28 | ¥252m |
| jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥5.8bn |
| jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥5.8bn |
| jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segment | revenue intersegment | 2022-06-01 → 2023-02-28 | ¥458,000 |
| jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segment | segment profit | 2022-06-01 → 2023-02-28 | −¥576m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-06-01 → 2023-02-28 | ¥12.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-06-01 → 2023-02-28 | ¥12.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-06-01 → 2023-02-28 | ¥139m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-06-01 → 2023-02-28 | −¥305m |
| Reconciling Itemsreconciling | revenue | 2021-06-01 → 2022-02-28 | −¥27m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-06-01 → 2022-02-28 | −¥27m |
| Reconciling Itemsreconciling | segment profit | 2021-06-01 → 2022-02-28 | −¥270m |
| jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segment | revenue | 2021-06-01 → 2022-02-28 | ¥2.0bn |
| jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segment | revenue external | 2021-06-01 → 2022-02-28 | ¥2.0bn |
| jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segment | revenue intersegment | 2021-06-01 → 2022-02-28 | ¥27m |
| jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segment | segment profit | 2021-06-01 → 2022-02-28 | ¥45m |
| jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segment | revenue | 2021-06-01 → 2022-02-28 | ¥2.6bn |
| jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segment | revenue external | 2021-06-01 → 2022-02-28 | ¥2.6bn |
| jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segment | segment profit | 2021-06-01 → 2022-02-28 | ¥666m |
| jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segment | revenue | 2021-06-01 → 2022-02-28 | ¥2.9bn |
| jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segment | revenue external | 2021-06-01 → 2022-02-28 | ¥2.9bn |
| jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segment | segment profit | 2021-06-01 → 2022-02-28 | ¥134m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-06-01 → 2022-02-28 | ¥7.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-06-01 → 2022-02-28 | ¥7.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-06-01 → 2022-02-28 | ¥27m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-06-01 → 2022-02-28 | ¥845m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 342
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)監査法人アヴァンティア | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)相 馬 裕 晃 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)橋 本 剛 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 7448815000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 12720969000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 11876681000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 549763000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | -709004000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 711729000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 352531000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | -603631000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 400519000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 352531000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | -558760000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 400284000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 4078174000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 4000462000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 4163534000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 5547564000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 7786050000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 6099295000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 80.60 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | -131.07 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 90.64 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | 76.33 | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | 86.68 | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.735 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.483 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.678 | |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | 43.28 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | -54.37 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 4892098 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 4892098 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 4892098 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 4982098 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 200000 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 4648800 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 46488 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 2224 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 4851024 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 46488 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 200000 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |